Login to Your Account

Financings Roundup

New Antibiotic Firm TetraPhase Raises $25M In Series A Round

By Aaron Lorenzo

Tuesday, November 28, 2006
With new antibiotic technology already yielding positive results, a start-up firm called TetraPhase Pharmaceuticals Inc. raised $25 million in its first round of venture capital backing. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription